Answers are grounded in this paper and cite their sources.
FOXM1 (Forkhead box M1) is a key regulator of tumorigenesis. Previous studies demonstrated that FOXM1 overexpression was strongly correlated with poor prognosis in various cancers, including hepatocellular carcinoma (HCC). In this study, we examined an association between the gene expression signature of FOXM1 and HCC patient outcome. The co-expressed gene set of FOXM1, which is significantly associated with the prognosis of HCC patients, was identified by analyzing the gene expression profiles of 100 patients with HCC, and this gene set was validated in two independent HCC patient cohorts (n=573). In multivariate analysis, the co-expressed gene set of FOXM1 was the most significant prognostic factor for overall survival in patients with HCC (hazard ratio=1.706, 95% confidence intervals=1.176–2.475, P=0.005). We also analyzed different types of cancer, including pancreatic adenocarcinoma, lung adenocarcinoma, breast carcinoma and bladder urothelial carcinoma, to verify the association between the co-expressed gene set of FOXM1 and patient prognosis, and we found a consistent prognostic significance, regardless of tumor type. Finally, we identified a putative signaling pathway in which miR-34a acts as an upstream regulator of the FOXM1-MYC signaling network; this pathway may be ultimately responsible for the poor prognosis of HCC patients. The prognostic subgroups defined by the gene expression signature of FOXM1 could help predict high-risk patients and may guide selection of the best treatment strategy. The expression of the FOXM1 gene could help predict high-risk patients and guide treatment strategies in hepatocellular carcinoma (HCC). Overexpression of FOXM1, a key regulator of tumor development and progression, has been linked to poor prognosis in various forms of cancer. In-Sun Chu and Bic-Na Song at the Korea Research Institute of Bioscience and Biotechnology in Daejeon investigated the association between FOXM1 expression and prognosis in patients with HCC, the most common form of liver cancer. They found the survival rates of patients with high levels of FOXM1 expression were significantly worse than those with low levels. Similar results were found in several other types of cancer. The authors concluded that the expression of FOXM1 and its associated genes has potential as a prognostic and predictive indicator in various cancers.
No takes yet. Share an insight, caveat, or question.
Song et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: